Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 152895, 8 pages
http://dx.doi.org/10.1155/2012/152895
Clinical Study

The Effect of Conventional and Mini-Invasive Cardiopulmonary Bypass on Neutrophil Activation in Patients Undergoing Coronary Artery Bypass Grafting

1Department of Clinical Immunology, Faculty of Medicine, Charles University, 50005 Hradec Kralove, Czech Republic
2Department of Cardiac Surgery, University Hospital, 50005 Hradec Kralove, Czech Republic

Received 30 June 2011; Accepted 14 November 2011

Academic Editor: Loek Leenen

Copyright © 2012 Martina Kolackova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Magee, K. A. Jablonski, S. C. Stamou et al., “Elimination of cardiopulmonary bypass improves early survival for multivessel coronary artery bypass patients,” Annals of Thoracic Surgery, vol. 73, no. 4, pp. 1196–1203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Swaminathan, B. G. Phillips-Bute, P. J. Conlon, P. K. Smith, M. F. Newman, and M. Stafford-Smith, “The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery,” Annals of Thoracic Surgery, vol. 76, no. 3, pp. 784–791, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Ohata, M. Mitsuno, M. Yamamura et al., “Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting,” Journal of Artificial Organs, vol. 10, no. 2, pp. 92–95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Biancari and R. Rimpiläinen, “Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery,” Heart, vol. 95, no. 12, pp. 964–969, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Saatvedt, H. Lindberg, S. Michelsen, T. Pedersen, E. Seem, and O. Geiran, “Release of soluble tumour necrosis factor alpha receptors during and after paediatric cardiopulmonary bypass. Correlation with haemodynamic and clinical variables,” Cytokine, vol. 8, no. 12, pp. 944–948, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Börgermann, I. Friedrich, S. Flohé et al., “Tumor necrosis factor-α production in whole blood after cardiopulmonary bypass downregulation caused by circulating cytokine-inhibitory activities,” Journal of Thoracic and Cardiovascular Surgery, vol. 124, no. 3, pp. 608–617, 2002. View at Google Scholar
  7. P.-A. Bécherel, L. LeGoff, C. Francès et al., “Cutting Edge: induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3,5-monophosphate-dependent mechanism,” Journal of Immunology, vol. 159, no. 12, pp. 5761–5765, 1997. View at Google Scholar
  8. C. Niemand, A. Nimmesgern, S. Haan et al., “Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3,” Journal of Immunology, vol. 170, no. 6, pp. 3263–3272, 2003. View at Google Scholar · View at Scopus
  9. D. F. Fiorentino, A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra, “IL-10 inhibits cytokine production by activated macrophages,” Journal of Immunology, vol. 147, no. 11, pp. 3815–3822, 1991. View at Google Scholar · View at Scopus
  10. A. Roth-Isigkeit, T. V. Borstel, M. Seyfarth, and P. Schmucker, “Perioperative serum levels of tumour-necrosis-factor alpha (TNF-α), IL- 1β, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution,” Clinical and Experimental Immunology, vol. 118, no. 2, pp. 242–246, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. G. D'Amico, G. Frascaroli, G. Bianchi et al., “Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys,” Nature Immunology, vol. 1, no. 5, pp. 387–391, 2000. View at Google Scholar · View at Scopus
  12. C. Bogdan, Y. Vodovotz, and C. Nathan, “Macrophage deactivation by interleukin 10,” Journal of Experimental Medicine, vol. 174, no. 6, pp. 1549–1555, 1991. View at Google Scholar · View at Scopus
  13. A. Domínguez Rodríguez, P. Abreu González, M. J. García González, and J. Ferrer Hita, “Association between serum interleukin 10 level and development of heart failure in acute myocardial infarction patients treated by primary angioplasty,” Revista Espanola de Cardiologia, vol. 58, no. 6, pp. 626–630, 2005. View at Publisher · View at Google Scholar
  14. Q. Shu, X. Fang, Q. Chen, and F. Stuber, “IL-10 polymorphism is associated with increased incidence of severe sepsis,” Chinese Medical Journal, vol. 116, no. 11, pp. 1756–1759, 2003. View at Google Scholar · View at Scopus
  15. H. F. Galley, P. R. Lowe, R. L. Carmichael, and N. R. Webster, “Genotype and interleukin-10 responses after cardiopulmonary bypass,” British Journal of Anaesthesia, vol. 91, no. 3, pp. 424–426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tabardel, J. Duchateau, D. Schmartz et al., “Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men,” Surgery, vol. 119, no. 1, pp. 76–80, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Howard, T. Muchamuel, S. Andrade, and S. Menon, “Interleukin 10 protects mice from lethal endotoxemia,” Journal of Experimental Medicine, vol. 177, no. 4, pp. 1205–1208, 1993. View at Google Scholar · View at Scopus
  18. S. Q. Latifi, M. A. O'Riordan, and A. D. Levine, “Interleukin-10 controls the onset of irreversible septic shock,” Infection and Immunity, vol. 70, no. 8, pp. 4441–4446, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. G. S. Musleh, S. S. Datta, N. N. Yonan et al., “Association of IL6 and IL10 with renal dysfunction and the use of haemofiltration during cardiopulmonary bypass,” European Journal of Cardio-Thoracic Surgery, vol. 35, no. 3, pp. 511–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Eagle, R. A. Guyton, R. Davidoff et al., “ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery),” Circulation, vol. 100, no. 13, pp. 1464–1480, 1999. View at Google Scholar · View at Scopus
  21. K. R. Kasten, J. T. Muenzer, and C. C. Caldwell, “Neutrophils are significant producers of IL-10 during sepsis,” Biochemical and Biophysical Research Communications, vol. 393, no. 1, pp. 28–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Liu, S. H. Y. Wei, A. S. Y. Ho, R. D. W. Malefyt, and K. W. Moore, “Expression cloning and characterization of a human IL-10 receptor,” Journal of Immunology, vol. 152, no. 4, pp. 1821–1829, 1994. View at Google Scholar · View at Scopus
  23. K. Ina, K. Kusugami, Y. Kawano et al., “Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosis,” Journal of Immunology, vol. 175, no. 3, pp. 2000–2009, 2005. View at Google Scholar · View at Scopus
  24. B. Muller, E. J. J. De Groot, I. J. M. Kortekaas, W. J. Fokkens, and C. M. Van Drunen, “Nasal epithelial cells express IL-10 at levels that negatively correlate with clinical symptoms in patients with house dust mite allergy,” Allergy, vol. 62, no. 9, pp. 1014–1022, 2007. View at Publisher · View at Google Scholar · View at Scopus